F Mornex

Summary

Country: France

Publications

  1. ncbi [Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]
    F Mornex
    Centre Hospitalier Lyon Sud, Service de radiothérapie oncologie, EA 643, 69495 cedex, Pierre Benite, France
    Cancer Radiother 7:1-8. 2003
  2. ncbi A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma
    F Mornex
    Centre Hospitalier Lyon Sud, Service de radiothérapie oncologie, Pierre Benite Cedex, France
    Melanoma Res 13:97-103. 2003
  3. ncbi [Treatment of stage III non-small lung carcinomas: is there controversy?]
    F Mornex
    Département d oncologie radiographie, Centre Hospitalier Lyon Sud, 69495 Pierre Benite Cedex, France
    Rev Pneumol Clin 62:2S20-3. 2006
  4. doi [Dosimetric impact of breath-hold in the treatment of hepatocellular carcinoma by conformal radiation therapy]
    A Kubas
    Service de radiothérapie oncologie, Centre hospitalier Lyon Sud Pierre Benite, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Cancer Radiother 13:24-9. 2009
  5. ncbi Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer
    A Belliere
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, Pierre Benite Cedex, France
    Cancer Radiother 13:298-304. 2009
  6. ncbi [Chemoradiation for pancreatic adenocarcinoma]
    I Flandin
    département de radiothérapie oncologie, EA 37 38, Centre Hospitalier Lyon Sud, 69495 Pierre Benite Cedex, France
    Cancer Radiother 8:S80-7. 2004
  7. ncbi Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
    R Le Scodan
    Department of Radiation Oncology, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Ann Oncol 20:1387-96. 2009
  8. ncbi [Preoperative radiotherapy of rectal cancer. The Lyons experience, 1985-1996. Prognostic study apropos of 312 patients]
    J P Gerard
    Service de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Ann Chir 53:1003-10. 1999
  9. ncbi [Chemoradiation for locally advanced non-small cell lung cancer]
    N Girard
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Cancer Radiother 11:67-76. 2007
  10. ncbi [Specificities of resectable Stage III non-small-cell lung cancer]
    Y Thibout
    Département d oncologie radiographie, Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Rev Pneumol Clin 60:4S5-4S7. 2004

Collaborators

Detail Information

Publications47

  1. ncbi [Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]
    F Mornex
    Centre Hospitalier Lyon Sud, Service de radiothérapie oncologie, EA 643, 69495 cedex, Pierre Benite, France
    Cancer Radiother 7:1-8. 2003
    ....
  2. ncbi A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma
    F Mornex
    Centre Hospitalier Lyon Sud, Service de radiothérapie oncologie, Pierre Benite Cedex, France
    Melanoma Res 13:97-103. 2003
    ....
  3. ncbi [Treatment of stage III non-small lung carcinomas: is there controversy?]
    F Mornex
    Département d oncologie radiographie, Centre Hospitalier Lyon Sud, 69495 Pierre Benite Cedex, France
    Rev Pneumol Clin 62:2S20-3. 2006
  4. doi [Dosimetric impact of breath-hold in the treatment of hepatocellular carcinoma by conformal radiation therapy]
    A Kubas
    Service de radiothérapie oncologie, Centre hospitalier Lyon Sud Pierre Benite, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Cancer Radiother 13:24-9. 2009
    ..To evaluate the dosimetric impact of breath-hold during radiotherapy of hepatocellular carcinoma (HCC) and to determinate the optimal respiratory phase for treatment (exhale or inhale)...
  5. ncbi Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer
    A Belliere
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, Pierre Benite Cedex, France
    Cancer Radiother 13:298-304. 2009
    ..Aware of the necessity to increase local control in locally advanced NSCLC, we analyzed the feasibility of high-dose three-dimensional conformal radiation therapy (3D-CRT) in the treatment of localised NSCLC...
  6. ncbi [Chemoradiation for pancreatic adenocarcinoma]
    I Flandin
    département de radiothérapie oncologie, EA 37 38, Centre Hospitalier Lyon Sud, 69495 Pierre Benite Cedex, France
    Cancer Radiother 8:S80-7. 2004
    ..This paper reviews the different therapeutic approaches of non metastatic pancreatic adenocarcinoma...
  7. ncbi Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
    R Le Scodan
    Department of Radiation Oncology, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Ann Oncol 20:1387-96. 2009
    ..We explored the feasibility and the histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma...
  8. ncbi [Preoperative radiotherapy of rectal cancer. The Lyons experience, 1985-1996. Prognostic study apropos of 312 patients]
    J P Gerard
    Service de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Ann Chir 53:1003-10. 1999
    ..Preoperative radiotherapy is used increasingly in rectal cancer in Europe. This study is a retrospective analysis of a series of 312 patients with rectal adenocarcinoma treated by preoperative radiotherapy...
  9. ncbi [Chemoradiation for locally advanced non-small cell lung cancer]
    N Girard
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Cancer Radiother 11:67-76. 2007
    ..New techniques of radiation may also increase the efficacy and the feasibility of radiation. This constant progress makes chemoradiation one of the most promising combined treatments in thoracic oncology...
  10. ncbi [Specificities of resectable Stage III non-small-cell lung cancer]
    Y Thibout
    Département d oncologie radiographie, Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Rev Pneumol Clin 60:4S5-4S7. 2004
  11. doi [Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of acute toxicities in a French centre and a review of the literature]
    B De Bari
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Chemin du Grand Revoyet, 69310 Pierre Benite, France
    Cancer Radiother 16:52-7. 2012
    ..To study the tolerance to radiotherapy, with or without chemotherapy, followed by brachytherapy, in elderly patients (75 years or older) suffering from anal cancer...
  12. ncbi [Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0]
    J P Gerard
    Service de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Pierre Benite
    Gastroenterol Clin Biol 24:430-5. 2000
    ..To study retrospectively the relapse rate, the functional results and the survival rate in patients with rectal carcinoma treated with local excision and adjuvant radiotherapy...
  13. ncbi [Gross tumor volume and clinical target volume in radiotherapy: lung cancer]
    F Mornex
    , EA 643, Centre Hospitalier Lyon-Sud, , France
    Cancer Radiother 5:659-70. 2001
    ..These different elements are discussed in this paper...
  14. ncbi [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer]
    N Girard
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, 165, Hospices Civils de Lyon, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, Lyon, France
    Cancer Radiother 11:59-66. 2007
    ....
  15. doi [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]
    M Barhoumi
    EA, département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Cancer Radiother 15:182-91. 2011
    ..To compare chemoradiation with systemic chemotherapy to chemotherapy alone in locally advanced pancreatic cancer...
  16. doi [Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature]
    T Chekrine
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Chemin du Grand Revoyet, Pierre Benite, France
    Cancer Radiother 15:250-3. 2011
    ..A review of the literature on this topic is also presented...
  17. ncbi [Stage IIIB non-small cell lung cancer. Optimization of radiotherapy in lung cancer: some interesting questions to be solved]
    N Girard
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Lyon, France
    Rev Mal Respir 23:16S61-16S67. 2006
    ..These developments make radiotherapy one of the most promising therapeutics in thoracic oncology...
  18. doi [Endobronchial brachytherapy: state of the art in 2013]
    N Derhem
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, 65, Chemin du Grand Revoyet, 69310 Pierre Benite, France
    Cancer Radiother 17:162-5. 2013
    ..CT-based dosimetry is a keypoint to optimize treatment quality and to minimize potential side effects, making this treatment a safe and efficient technique for specific indications...
  19. doi [Normal tissue tolerance to external beam radiation therapy: liver]
    B De Bari
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1 et EA3738, 69310 Pierre Benite, France
    Cancer Radiother 14:344-9. 2010
    ..e., the clinical event limiting the total dose that could be delivered. This review describes radiobiological criteria justifying the NTCP data, and recommendations for conformal 3D radiotherapy and stereotactic liver irradiation...
  20. ncbi Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art
    F Mornex
    Department of Radiotherapy Oncology, Centre Hospitalier Lyon Sud, Lyon, France
    Ann Oncol 17:1743-7. 2006
    ..Gemcitabine used concurrently with radiation, as an induction regimen before radiation, and as a consolidation regimen after radiation is reviewed...
  21. ncbi [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial]
    F Mornex
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Cancer Radiother 9:470-6. 2005
    ..This trial was designed to assess the efficacy and tolerance of CRT for small-size HCC in cirrhotic patients...
  22. ncbi [Early-stage NSCLC. The renaissance of radiotherapy in early-stage non-small cell lung cancer]
    N Girard
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Universite de Lyon, Lyon, France
    Rev Mal Respir 25:3S79-87. 2008
    ..More than ever, radiotherapy is one of the most promising therapeutic option for lung cancer...
  23. ncbi [Irradiation of hepatocellular carcinoma: impact of breathing on motions and variations of volume of the tumor, liver and upper abdominal organs]
    A Kubas
    Service de radiothérapie oncologie Rhône Alpes, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Cancer Radiother 12:768-74. 2008
    ..To evaluate the amplitude of motion and the variations of volume of the tumor, the liver and upper abdominal organs induced by breathing during the irradiation of hepatocellular carcinoma (HCC)...
  24. doi Radiotherapy of the pancreas: state of the art in 2012
    F Mornex
    Radiation Oncology Department, Centre Hospitalier Lyon Sud, Universite Claude Bernard, EA 3738, Lyon, France
    Recent Results Cancer Res 196:89-103. 2012
    ..1994; Bramhall et al. 1995; Bramhall et al. 1998; Parkin et al. 2001; Jemal et al. 2002)...
  25. doi [Single French centre retrospective analysis of local control after high dose radiotherapy with or without chemotherapy and local control for Pancoast tumours]
    B De Bari
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Chemin du Grand Revoyet, Pierre Benite, France
    Cancer Radiother 16:107-14. 2012
    ..The aim of this preliminary retrospective report is to present outcomes of patients affected by a superior sulcus non-small cell lung cancer, treated by high dose radiotherapy (>60 Gy) with or with our chemotherapy...
  26. ncbi [Which treatments should be proposed in resectable stage III cancers?]
    Y Thibout
    Département d Oncologie Radiothérapie, EA 643, Centre Hospitalier Lyon Sud, 69310 Pierre Benite
    Rev Pneumol Clin 60:3S37-42. 2004
    ..The place of chemotherapy, radiotherapy and even surgery in the treatment of resectable stage III NSCLC remains to be defined and the inclusion of patients in randomised clinical trials is recommended...
  27. doi [Oligometastatic disease, a new concept: stereotactic irradiation for lung metastases. Literature review]
    M Hatime
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Cancer Radiother 16:351-7. 2012
    ..Quality of life after stereotactic radiotherapy should be in a near future an important parameter to support this therapeutic choice, and needs to be precisely assessed...
  28. doi [Stereotactic intracranial radiotherapy: dose prescription]
    M Schlienger
    Service de radiothérapie oncologie, Hopital Tenon, 4 rue de la Chine, Paris, France
    Cancer Radiother 16:S38-45. 2012
    ....
  29. ncbi [Locally advanced non-small-cell bronchial cancer: role of exclusive chemoradiotherapy]
    F Mornex
    Département d Oncologie Radiothérapie, EA 643, Centre Hospitalier Lyon Sud, 69310 Pierre Benite, France
    Cancer Radiother 6:117s-124s. 2002
    ..An increased toxicity is observed, and the advent of conformal therapy may allow another survival gain. Optimal treatments integration will be necessary...
  30. doi [Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: state of the art]
    B De Bari
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, Chemin du Grand Revoyet, Pierre Benite, France
    Cancer Radiother 15:72-6. 2011
    ..This review summarises published data on stereotactic radiotherapy for the treatment of liver metastases...
  31. ncbi Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature
    J P Gerard
    Department of Radiotherapy Oncology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France
    Cancer 92:77-84. 2001
    ....
  32. ncbi [Chemoradiation in pancreatic carcinoma]
    L Claude
    département de radiothérapie oncologie, Centre Hospitalier Lyon Sud, 69495 cedex, Pierre Benite, France
    Cancer Radiother 7:254-65. 2003
    ..The last part concerns the most important and recent studies about chemoradiation in locally advanced pancreatic cancer, either with 5-fluoro-uracile or based on new drugs like gemcitabine...
  33. doi [4D-CT scan and radiotherapy for hepatocellular carcinoma: role in the definition of internal target volume (ITV)]
    B De Bari
    EA3738, université Claude Bernard Lyon 1 chemin du Grand Revoyet, Pierre Benite, France
    Cancer Radiother 15:43-8. 2011
    ..To evaluate the role of 4D-CT scan and the breath-related margins in the definition of internal target volume (ITV) during radiotherapy for hepatocellular carcinoma...
  34. doi [Platinum salts hypersensitivity]
    S Couraud
    Service de radiothérapie et oncologie, Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet, Pierre Benite Cedex, France
    Rev Pneumol Clin 64:20-6. 2008
    ..If it's necessary, careful replacement by another platin salt can be possible, eventually in accordance with results of IDR to all platinum salt...
  35. ncbi [Preoperative chemotherapy and chemoradiotherapy for non-small-cell bronchial cancers]
    B Milleron
    Service de Pneumologie, Hopital Tenon, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 6:105s-113s. 2002
    ..These observations suggest that the clinical research should now be different for stages I and II, and stage IIIA...
  36. ncbi [Non-small cell bronchial carcinoma: optimisation of radiotherapy]
    F Mornex
    Service de pnuemologie, Hopital Louis Pradel, Lyon, France
    Rev Mal Respir 22:8S124-30. 2005
    ..Radiotherapy is involved in several ways in the treatment of non-small cell bronchial carcinoma (NSCBC)...
  37. ncbi Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial
    G Freyer
    Department of Radiation Oncology, Medical Oncology Unit, Centre Hospitalier Lyon-Sud, , France
    J Clin Oncol 19:2433-8. 2001
    ..Although the MTD was not reached in this study, we recommend oxaliplatin 130 mg/m2 for phase II studies because it is the dose determined from studies in metastatic patients with no toxicity when given concurrently with radiation...
  38. ncbi [Local control in the management of cancer: a few thoughts]
    J P Gerard
    Service de radiothérapie cancérologie, Centre Hospitalier Lyon Sud, 69495 Pierre Benite Cedex
    Bull Cancer 88:693-9. 2001
    ..In case of organ preserving treatment, a complete local control is necessary from the start. If a too high risk of local relapse is foreseable, conservative treatment should not be recommended...
  39. ncbi [Chemoradiation therapy optimization for stage III NSCLC]
    F Mornex
    Departement de Radiotherapie, Centre Hospitalier Lyon Sud, Chemin du Grand Revoyer, 69495 Pierre Benite
    Rev Pneumol Clin 59:S15-20. 2003
  40. ncbi [Neoadjuvant chemoradiation in non-small cell lung cancer]
    B Milleron
    Unité fonctionnelle de cancérologie thoracique, CancerEst, Hopital Tenon, 4, rue de la Chine, 75970 Paris Cedex 20, France
    Cancer Radiother 11:36-40. 2007
    ..These developments make of the treatment of locally advanced non-small cell lung cancer a model for multimodal therapeutic strategies combining chemotherapy, radiotherapy and surgery...
  41. ncbi [Gemcitabine and radiotherapy for the future]
    N Girard
    Cancer Radiother 11:167-8. 2007
  42. doi [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations]
    V Boige
    Departement de Medecine, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Gastroenterol Clin Biol 32:3-7. 2008
  43. ncbi Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2
    B Chauffert
    Department of Oncology, Anticancer Center G F Leclerc, Dijon, France
    Ann Oncol 19:1592-9. 2008
    ..The role of chemoradiation with systemic chemotherapy compared with chemotherapy alone in locally advanced pancreatic cancer (LAPC) is uncertain...
  44. ncbi [Surgery and chemoradiation in stage IIIA non-small cell lung cancer]
    C Hennequin
    Service de cancérologie radiothérapie, Hopital Saint Louis, 1, avenue Claude Vellefeaux, 75010 Paris, France
    Cancer Radiother 10:477-83. 2006
    ..These developments make treatment of locally advanced non-small cell lung cancer a model for multimodal strategies in oncology, combining chemotherapy, radiotherapy and surgery...
  45. pmc Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
    A W Blackstock
    Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Blvd, Winston Salem, NC 27157, USA
    Br J Cancer 95:260-5. 2006
    ..These results confirm the feasibility of delivering adjuvant concurrent gemcitabine and radiation to the upper abdomen. This strategy produced good local regional tumour control...
  46. ncbi [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers]
    F Mornex
    Rev Pneumol Clin 58:3S37-41. 2002
  47. ncbi [Role of pemetrexed given with radiotherapy]
    F Mornex
    Département d Oncologie Radiothérapie, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex
    Rev Pneumol Clin 61:4S18-9. 2005